Figure 5.
Phase III trials of anti-inflammatory agents under evaluation in cardiovascular disease. Trials are grouped by agents that do and do not impact primarily on the central IL-1, TNF-α, IL-6 signalling system.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.